Scientists developing implant to cure cancer

[{"selector":"#anim-102e0c68-925f-46a3-aa6b-9664d80ed2e9","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0b0493c1-7026-4251-adae-a3349a4b8988","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9ed2107c-cf8c-4b46-b3c3-98f36776c855","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}] [{"selector":"#anim-30220811-51c2-46ef-892a-021abc13be36","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-23a1132e-0bcd-4b50-8030-813d30b287bd","keyframes":{"transform":["translate3d(0px, 181.96250%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] HEALTH Learn more

[{"selector":"#anim-cbf870ca-4b16-4659-b7a2-c3aaec953385","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f23cce20-c6ce-480a-8f98-91f2b80e238b","keyframes":{"transform":["translate3d(115.28663%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Curing cancer could soon be as easy as a few taps on your mobile, according to a team of scientists at Rice University who have received $45 million in funding for a novel, implant-based treatment system that could cut cancer death rates by 50%.

[{"selector":"#anim-9c108567-26db-4cfe-a3ed-9760c9e6edc7","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-391fa738-e472-4926-ad79-df1fa47b22d7","keyframes":{"transform":["translate3d(115.60510%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] The funds, granted by the Advanced Research Projects Agency for Health, will be used to develop “sense-and-respond implant technology,” with the aim to improve the outcomes of immunotherapy treatments for cancers that are usually difficult to treat.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time.”

[{"selector":"#anim-ef2261fd-df44-4257-8342-0b4b51743c81","keyframes":{"opacity":[0,1]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cf02b10c-19db-4902-94df-80063f6b0623","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e44e713c-4ee4-45eb-8abc-76c0c5c0b97d","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-79c2e800-e552-464c-8783-4c3748be3b82","keyframes":{"opacity":[0,1]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5cad9052-8c02-4744-883c-4459b7caa5c1","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Omid Veiseh Rice bioengineer and principal investigator on the project

[{"selector":"#anim-11f4319c-4755-4b0f-96c7-fcc3dc484ddc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9c85f10b-4a76-46fa-82b1-33d5bfb19f0e","keyframes":{"transform":["translate3d(115.28663%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Similarly to diabetes treatments with insulin pumps, the three-inch implant, or “hybrid advanced molecular manufacturing regulator” (HAMMR), would deliver immunotherapy drugs to the patient in a “closed loop” system. The chargeable devices will communicate wirelessly, “potentially with a smartphone.”

[{"selector":"#anim-4e9d2cf9-9bfd-4ac2-a829-c32f13030b83","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d4fc2f34-e1cf-47a1-9281-65e6fbfa7076","keyframes":{"transform":["translate3d(116.24204%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Researchers hope that the implant will only be needed for short-term use — eradicating the cancer in as little as 60 days.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process."

[{"selector":"#anim-d262c608-61f9-46bf-8969-d9808b2bb8be","keyframes":{"opacity":[0,1]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-26c8b07e-1c77-4795-8d83-860b40a8e37c","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-adf09d1d-343f-489f-8d09-c58a74aa49c0","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1a9ab08c-2cac-467b-a699-9a925017c2e4","keyframes":{"opacity":[0,1]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-07880296-1bff-46b0-8d94-ef2c26f44a5c","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Dr. Amir Jazaeri Professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center

“As a result, today’s therapies treat cancer as if it were a static disease.”

[{"selector":"#anim-9d218e95-ae8f-4543-90d4-a9b34b6c65da","keyframes":{"opacity":[0,1]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-17eee721-9bed-4e87-9abb-a06eb5719c77","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5a858c7a-2bd0-4d1a-8339-49077540133d","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-881aea2d-f24a-4748-a7c5-04106f3ba5db","keyframes":{"opacity":[0,1]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5a575429-7943-4c20-a240-d1bf95a6c62b","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":500,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Dr. Amir Jazaeri Professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center

[{"selector":"#anim-45b894fd-b29c-4c29-9548-52694cb3d0a6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-eecea10a-2a77-4eee-9f3b-d1531bf8a38c","keyframes":{"transform":["translate3d(115.92356%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Instead, their technology, which serves as both a cancer monitoring and drug administrating system, will provide “real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies” and, therefore, expedite the treatment process.

Discovering my adult ADHD diagnosis

[{"selector":"#anim-a4d557d9-9ca4-4d2e-9b47-c99d16100c68","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bd2dbb15-6eb3-41f5-a974-2e889128e946","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-48f54e95-a660-4a70-ba32-829bce7e1f1a","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}] [{"selector":"#anim-e137aa1e-dae4-406b-afaa-6733970dbe46","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-666bced5-5f6e-4202-874a-3cc751f95201","keyframes":{"transform":["translate3d(0px, 269.14777%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9546889c-e8c3-4183-968d-26a931bac48e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e34f7900-2786-4588-807e-b52bd152110c","keyframes":{"transform":["translate3d(0px, -845.35176%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Learn more

STAY UP-TO-DATE ON THE LATEST BREAKING NEWS

[{"selector":"#anim-b6a6fec8-0112-4fa7-9893-b227b06fc517","keyframes":{"opacity":[0,1]},"delay":500,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-aae34039-ddae-400d-89f4-d1ed06f35010","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}] [{"selector":"#anim-a3f25111-b9e1-474b-a525-574f1225b9f1","keyframes":{"opacity":[0,1]},"delay":1000,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Learn more